Karita Särekannu
University of Tartu(EE)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, Diabetes and associated disorders, Long-Term Effects of COVID-19, T-cell and B-cell Immunology
Most-Cited Works
- → Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths(2021)617 cited
- → The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies(2022)183 cited
- → Autoantibodies against type I IFNs in patients with critical influenza pneumonia(2022)125 cited
- → Inactive disease in patients with lupus is linked to autoantibodies to type I interferons that normalize blood IFNα and B cell subsets(2023)44 cited
- → Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children(2024)38 cited
- → Autoantibodies Neutralizing Type III Interferons Are Uncommon in Patients with Severe Coronavirus Disease 2019 Pneumonia(2023)25 cited
- → The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies(2022)24 cited
- Autoantibodies neutralizing type I IFNs are present in similar to 4% of uninfected individuals over 70 years old and account for similar to 20% of COVID-19 deaths(2021)